Rab-coupling protein coordinates recycling of α5β1 integrin and EGFR1 to promote cell migration in 3D microenvironments

被引:313
作者
Caswell, Patrick T. [1 ]
Chan, May [2 ]
Lindsay, Andrew J. [3 ]
McCaffrey, Mary W. [3 ]
Boettiger, David [2 ]
Norman, Jim C. [1 ]
机构
[1] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
[2] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA
[3] Univ Coll Cork, Biosci Inst, Dept Biochem, Mol Cell Biol Lab, Cork, Ireland
基金
美国国家卫生研究院; 爱尔兰科学基金会;
关键词
D O I
10.1083/jcb.200804140
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Here we show that blocking the adhesive function of alpha v beta 3 integrin with soluble RGD ligands, such as osteopontin or cilengitide, promoted association of Rab-coupling protein (RCP) with alpha 5 beta 1 integrin and drove RCP-dependent recycling of alpha 5 beta 1 to the plasma membrane and its mobilization to dynamic ruffling protrusions at the cell front. These RCP-driven changes in alpha 5 beta 1 trafficking led to acquisition of rapid/random movement on two-dimensional substrates and to a marked increase in fibronectin-dependent migration of tumor cells into three-dimensional matrices. Recycling of alpha 5 beta 1 integrin did not affect its regulation or ability to form adhesive bonds with substrate fibronectin. Instead, alpha 5 beta 1 controlled the association of EGFR1 with RCP to promote the coordinate recycling of these two receptors. This modified signaling downstream of EGFR1 to increase its autophosphorylation and activation of the proinvasive kinase PKB/Akt. We conclude that RCP provides a scaffold that promotes the physical association and coordinate trafficking of alpha 5 beta 1 and EGFR1 and that this drives migration of tumor cells into three-dimensional matrices.
引用
收藏
页码:143 / 155
页数:13
相关论文
共 56 条
[41]   Tumor-derived osteopontin is soluble, not matrix associated [J].
Rittling, SR ;
Chen, YP ;
Feng, F ;
Wu, YM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (11) :9175-9182
[42]   PDGF-regulated rab4-dependent recycling of αvβ3 integrin from early endosomes is necessary for cell adhesion and spreading [J].
Roberts, M ;
Barry, S ;
Woods, A ;
van der Sluijs, P ;
Norman, J .
CURRENT BIOLOGY, 2001, 11 (18) :1392-1402
[43]   Mechanisms of cancer cell invasion [J].
Sahai, E .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (01) :87-96
[44]   Src kinase modulates the activation, transport and signalling dynamics of fibroblast growth factor receptors [J].
Sandilands, Emma ;
Akbarzadeh, Shiva ;
Vecchione, Anna ;
McEwan, David G. ;
Frame, Margaret C. ;
Heath, John K. .
EMBO REPORTS, 2007, 8 (12) :1162-1169
[45]   alpha v beta 3 integrin associates with activated insulin and PDGF beta receptors and potentiates the biological activity of PDGF [J].
Schneller, M ;
Vuori, K ;
Ruoslahti, E .
EMBO JOURNAL, 1997, 16 (18) :5600-5607
[46]   A novel mode for integrin-mediated signaling: Tethering is required for phosphorylation of FAK Y397 [J].
Shi, Q ;
Boettiger, D .
MOLECULAR BIOLOGY OF THE CELL, 2003, 14 (10) :4306-4315
[47]   Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2 [J].
Soldi, R ;
Mitola, S ;
Strasly, M ;
Defilippi, P ;
Tarone, G ;
Bussolino, F .
EMBO JOURNAL, 1999, 18 (04) :882-892
[48]   AP-1 differentially expressed proteins Krp1 and fibronectin cooperatively enhance Rho-ROCK-independent mesenchymal invasion by altering the function, localization, and activity of nondifferentially expressed proteins [J].
Spence, HJ ;
McGarry, L ;
Chew, CS ;
Carragher, NO ;
Scott-Carragher, LA ;
Yuan, ZQ ;
Croft, DR ;
Olson, MF ;
Frame, M ;
Ozanne, BW .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (04) :1480-1495
[49]   Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways [J].
Tuck, AB ;
Hota, C ;
Wilson, SM ;
Chambers, AF .
ONCOGENE, 2003, 22 (08) :1198-1205
[50]   Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells [J].
Tuck, AB ;
Arsenault, DM ;
O'Malley, FP ;
Hota, C ;
Ling, MC ;
Wilson, SM ;
Chambers, AF .
ONCOGENE, 1999, 18 (29) :4237-4246